To verify whether TKI could also affect the functional activity of CD56+ cells, we analyzed the intra-cytoplasmic cytokine expression and the cytolytic activity against the NK-susceptible K562 human leukemia cell line. The gene discussed is NCAM1; the disease is leukemia.